Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett King

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Clinics in Dermatology|December 18, 2024
Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatmentWilliam Damsky, Brett King
Dermatologic Clinics|November 14, 2024
Innovation in Alopecia AreataLuiza Kalil, Brett King
Drugs|September 25, 2025
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic PotentialCésar Ferreira, Brett King, Tiago Torres
Journal of Dentistry for Children (Chicago, Ill.)|July 22, 2009
Limited opening secondary to Lyme disease in an 8-year-old childD Harvey Lee, Paul K Chu, Brett King, et al.
Dental Traumatology : Official Publication of International Association for Dental Traumatology|December 13, 2016
Interdisciplinary approach to education: preparing general dentists to manage dental traumaJanice Townsend, Brett King, Richard Ballard, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|October 25, 2020
Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey StudyNatasha Mesinkovska, Brett King, Paradi Mirmirani, et al.
The Yale Journal of Biology and Medicine|April 1, 2020
The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the LiteratureAlice Wang, Katelyn Singh, Wael Ibrahim, et al.
The New England Journal of Medicine|December 27, 2018
Tofacitinib Treatment and Molecular Analysis of Cutaneous SarcoidosisWilliam Damsky, Durga Thakral, Nkiruka Emeagwali, et al.
Cells|August 27, 2025
A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia AreataRobert Gensure, Brett King, Stephen Sikkink, et al.
Archives of Dermatology|February 18, 2009
Palifermin-associated papular eruptionBrett King, Eleanor Knopp, Anjela Galan, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Clinics in Dermatology|December 18, 2024
Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatmentWilliam Damsky, Brett King
Dermatologic Clinics|November 14, 2024
Innovation in Alopecia AreataLuiza Kalil, Brett King
Drugs|September 25, 2025
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic PotentialCésar Ferreira, Brett King, Tiago Torres
Journal of Dentistry for Children (Chicago, Ill.)|July 22, 2009
Limited opening secondary to Lyme disease in an 8-year-old childD Harvey Lee, Paul K Chu, Brett King, et al.
Dental Traumatology : Official Publication of International Association for Dental Traumatology|December 13, 2016
Interdisciplinary approach to education: preparing general dentists to manage dental traumaJanice Townsend, Brett King, Richard Ballard, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|October 25, 2020
Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey StudyNatasha Mesinkovska, Brett King, Paradi Mirmirani, et al.
The Yale Journal of Biology and Medicine|April 1, 2020
The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the LiteratureAlice Wang, Katelyn Singh, Wael Ibrahim, et al.
The New England Journal of Medicine|December 27, 2018
Tofacitinib Treatment and Molecular Analysis of Cutaneous SarcoidosisWilliam Damsky, Durga Thakral, Nkiruka Emeagwali, et al.
Cells|August 27, 2025
A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia AreataRobert Gensure, Brett King, Stephen Sikkink, et al.
Archives of Dermatology|February 18, 2009
Palifermin-associated papular eruptionBrett King, Eleanor Knopp, Anjela Galan, et al.
Pageof 8